Assay ID | Title | Year | Journal | Article |
AID1178404 | Inhibition of RAD1 (unknown origin) binding to ssDNA | 2014 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
| Targeting the homologous recombination pathway by small molecule modulators. |
AID724821 | Inhibition of human RAD51 binding to single stranded DNA by fluorescence polarization assay | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID528201 | Inhibition of N-terminal FITC BH3 peptide binding to GST-tagged Bfl1 by fluorescence polarization assay | 2010 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
| Inhibition of Bfl-1 with N-aryl maleimides. |
AID1309743 | Inhibition of Escherichia coli BL21(DE3) expressing human N-terminal 6-histidine/Avi-tagged RAD51 binding to circular pRS306 virion ssDNA preincubated for 40 mins followed by ssDNA addition measured after 5 mins by agarose gel electrophoresis | 2016 | Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
| Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. |
AID724820 | Cytotoxicity against HEK293 cells after 24 hrs | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID724818 | Half life of the compound in DMSO at 10 mg by HPLC analysis in the presence of glutathione | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID724819 | Induction of sensitization to Mitomycin C in HEK293 cells after 24 hrs | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID1309744 | Effect on stabilization of Escherichia coli BL21(DE3) expressing human N-terminal 6-histidine/Avi-tagged RAD51-circular pRS306 virion ssDNA nucleoprotein filament at 30 uM after 40 mins in presence of NaCl by SYBR gold staining based agarose gel electroph | 2016 | Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
| Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. |
AID528202 | Inhibition of N-terminal FITC BH3 peptide binding to GST-tagged Bfl1 by time resolved-FRET assay | 2010 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
| Inhibition of Bfl-1 with N-aryl maleimides. |
AID724822 | Inhibition of human RAD51 binding to single stranded DNA at 59 uM by fluorescence polarization based assay | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID724817 | Irreversible inhibition of human RAD51 binding to single stranded DNA at 10 uM after 30 mins by fluorescence polarization based assay | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID724814 | Inhibition of RAD51-mediated homologous recombination in HEK293 cells at 20 uM after 24 hrs by reporter gene assay based FACS analysis | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID724813 | Inhibition of RAD51 in HEK293 cells assessed as stimulation of single strand annealing at 20 uM after 24 hrs by reporter gene assay based FACS analysis | 2013 | Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
| An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |